Chas P. Smith & Associates (CPS)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
1,254
+40
+3% +$40.6K 0.06% 72
2025
Q4
$1.3M Buy
1,214
+694
+133% +$664K 0.07% 68
2025
Q3
$397K Sell
520
-683
-57% -$508K 0.03% 89
2025
Q2
$938K Sell
1,203
-144
-11% -$112K 0.05% 73
2025
Q1
$1.11M Hold
1,347
0.06% 69
2024
Q4
$1.04M Sell
1,347
-195
-13% -$161K 0.06% 70
2024
Q3
$1.37M Buy
1,542
+8
+0.5% +$7.19K 0.08% 62
2024
Q2
$1.39M Buy
1,534
+35
+2% +$28K 0.08% 61
2024
Q1
$1.17M Buy
1,499
+61
+4% +$43.4K 0.07% 63
2023
Q4
$838K Buy
1,438
+100
+7% +$58.4K 0.06% 55
2023
Q3
$719K Buy
1,338
+147
+12% +$75.7K 0.05% 58
2023
Q2
$559K Buy
1,191
+125
+12% +$52.4K 0.04% 69
2023
Q1
$366K Sell
1,066
-6
-0.6% -$2.02K 0.02% 87
2022
Q4
$392K Sell
1,072
-54
-5% -$19.1K 0.03% 81
2022
Q3
$364K Buy
1,126
+80
+8% +$25.3K 0.03% 78
2022
Q2
$339K Hold
1,046
0.02% 87
2022
Q1
$300K Buy
1,046
+48
+5% +$12.4K 0.02% 97
2021
Q4
$276K Sell
998
-5
-0.5% -$1.27K 0.02% 112
2021
Q3
$232K Sell
1,003
-20
-2% -$4.94K 0.02% 116
2021
Q2
$235K Buy
+1,023
New +$205K 0.02% 114

Other funds holding LLY

Chas P. Smith & Associates (CPS)'s LLY Position: Q1 2026 in Review

Chas P. Smith & Associates (CPS) increased its Eli Lilly (LLY) stake by 3.3% in Q1 2026, buying an estimated $40.6K and bringing the position to 1,254 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #72.

Chas P. Smith & Associates (CPS) first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.39M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Chas P. Smith & Associates (CPS) held 1,254 shares of Eli Lilly worth $1.15M as of Q1 2026.
  • Chas P. Smith & Associates (CPS) bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
  • Eli Lilly made up 0.06% of Chas P. Smith & Associates (CPS)'s portfolio in Q1 2026, its #72 holding.
  • Chas P. Smith & Associates (CPS) first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
  • Chas P. Smith & Associates (CPS)'s Eli Lilly position peaked at $1.39M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Chas P. Smith & Associates (CPS)'s 13F filing for Q1 2026, filed 12 May 2026.